Emerging third-generation sequencing technologies (PacBio SMRT and Oxford Nanopore sequencing) can detect DNA and RNA methylation modifications directly. These newer sequencing technologies provide promising tools for further discovery of the mechanisms and functions of RNA methylation modifications. CD Genomics is based on the Oxford Nanopore sequencing platform to provide low-cost, high-efficiency, and high-accuracy RNA methylation identification and analysis. Our service enables direct identification of natural or synthetic RNA base modifications at nucleotide resolution, including N6-methyladenosine modification (m6A), 5-methylcytosine modification (m5C), and so forth.
In recent years, with the development of high-throughput sequencing technology and the discovery of RNA methylation-related proteins, great progress has been made in RNA modification research. Nowadays, there are more than 150 RNA modifications have been detected and identified, and they have been found in messenger RNA (mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), and other noncoding small RNA (sncRNA).
RNA methylation is a kind of post-transcriptional regulation method. The major mammalian RNA methylation modifications include m6A, m5C, N1-methyladenosine (m1A), and pseudouridine modification (Ψ), but previous studies have mainly focused on m6A. Here, we give a brief overview of RNA m6A and its posttranscriptional regulation. m6A is the most common methylation modification in RNA, mainly distributed in long exons, stop codons, and in 3’UTRs. It is present in a variety of RNAs, with the highest abundance in mRNA. Similar to DNA methylation, m6A RNA methylation is characterized by dynamic and reversible in mammalian cells. As the most studied RNA methylation, m6A has been demonstrated that play an important role in RNA metabolism in terms of mRNA alternative polyadenylation, stability, and transport. Furthermore, m6A is closely associated with physiological processes such as cell differentiation, inflammation, and immunity. Aberrant m6A methylation has been reported to be implicated in obesity, cancer, neurodegeneration, and other pathologies.
Fig1. Molecular composition of m6A RNA methylation. (Chen, X. Y., et al., 2019)
-Sample type: conventional plant and animal samples.
-Recommended library inputs of 10 µg of RNA.
-Sequencing strategy: non-PCR amplification library construction, Nanopore PromethION platform.
CD Genomics is committed to providing an effective solution for assessing RNA methylation for animals and plants. If you are interested in our services, please don't hesitate to contact us. We've got everything covered for your needs and are ready to assist.
For research purposes only, not intended for personal diagnosis, clinical testing, or health assessment